Stay updated with breaking news from Nvta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research note issued on Wednesday. The firm set a “hold” rating on the medical research company’s stock. Invitae Stock Performance NYSE NVTA opened at $0.00 on Wednesday. The stock has a market capitalization of $267,010.00, a P/E ratio of 0.00 and […] ....
Stock analysts at StockNews.com assumed coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research note issued on Monday. The firm set a “hold” rating on the medical research company’s stock. Invitae Stock Performance NYSE NVTA opened at $0.02 on Monday. The firm’s fifty day moving average price is $0.44 and its […] ....
Stock analysts at StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, The Goldman Sachs Group lowered their target price on Invitae from $1.00 to $0.50 and set a “sell” rating on […] ....
StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, The Goldman Sachs Group cut their target price on Invitae from $1.00 to $0.50 and set a “sell” rating for the […] ....
StockNews.com began coverage on shares of Invitae (NYSE:NVTA – Free Report) in a research report report published on Friday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, The Goldman Sachs Group decreased their price objective on Invitae from $1.00 to $0.50 and set a sell rating for the company […] ....